Keyphrases
Lima
100%
Peru
100%
Molecular Characterization
100%
Tertiary Hospital
100%
Carbapenemase-producing Enterobacterales
100%
Klebsiella Pneumoniae (K. pneumoniae)
66%
KPC-2
66%
Peruvian
33%
Transposon
33%
BlaNDM-1 Gene
33%
ST147
33%
Tn4401
33%
ISAba125
33%
Current Treatment
16%
Resistance Mechanisms
16%
Sequence Type
16%
Prevention Strategies
16%
Treatment Strategy
16%
Control Program
16%
Resistance Level
16%
Escherichia Coli Isolates
16%
Multidrug-resistant
16%
Virulence Factors
16%
High-risk Clone
16%
Genetic Structure
16%
Resistance Factor
16%
ST11
16%
BlaNDM-1
16%
Colistin Resistance
16%
Carbapenemases
16%
Prevention Programs
16%
Antimicrobial Resistance Surveillance
16%
Resistance Genes
16%
Whole Genome Sequencing
16%
NDM-1
16%
Global Health
16%
Virulence Mechanisms
16%
Extensively Drug-resistant
16%
Low-income Settings
16%
Control Measures
16%
Middle-income Setting
16%
Low-middle Income
16%
Metallo-β-lactamase
16%
Antibiotic Stewardship Program
16%
Enterobacter Hormaechei
16%
Carbapenemase Genes
16%
Outbreak Prevention
16%
Frequent Sequence
16%
Spread of Resistance
16%
Difficult-to-treat Infections
16%
Tn125
16%
PmrB
16%
Genomic Surveillance
16%
Serine Carbapenemase
16%
Phenotypic Antimicrobial Susceptibility Testing
16%
Resistant Bacteria
16%
Escherichia Coli ST410
16%
Klebsiella
16%
Current Control
16%
Outbreak Control
16%
Immunology and Microbiology
Enterobacterales
100%
Klebsiella pneumoniae
50%
Escherichia coli
33%
Transposon
33%
Antimicrobial Resistance
16%
Virulence Factor
16%
Antibiotic Sensitivity
16%
Colistin
16%
Gene Structure
16%
Whole Genome Sequencing
16%
Enterobacter
16%
Genomic Surveillance
16%
Klebsiella
16%
Biochemistry, Genetics and Molecular Biology